🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II, randomized, double-blind, active-controlled study to ev...
Status
Completed
Location
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Start Date
2019-01-24
Trial ID
NCT03589768
This pivotal safety trial aims to extend the safety database for BioNet rec...
Status
Active Not Recruiting
Location
Chula Clinical Research Center (Chula CRC)
Start Date
2025-02-08
Trial ID
NCT06798831
Treatments Being Tested
The aim of the study was to investigate the immunogenicity and safety of CY...
Status
Terminated
Location
Multiple Locations
Start Date
2016-12-19
Trial ID
NCT02992418
The goal of this clinical trial is to investigate the safety and tetanus an...
Status
Completed
Location
ABO Plasma
Start Date
2023-05-05
Trial ID
NCT05662852
Treatments Being Tested
It is well recognized that older adults can contract pertussis, suffer its ...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00457249
Currently, there is no 5-component acellular pertussis vaccine licensed for...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00467519
Objectives: To provide safety data on revaccination with ADACEL® vaccine. ...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00347958
Treatments Being Tested
This was a dose and formulation ranging study to assess the safety and immu...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-22
Trial ID
NCT02587520
Treatments Being Tested
The primary objectives of this study are: * To describe the safety profile...
Status
Completed
Location
Investigational Site Number 1240006
Start Date
2019-06-26
Trial ID
NCT03958799
The main objective is to determine whether immune responses to Tdap (GlaxoS...
Status
Completed
Location
Birmingham Pediatrics, 806 Saint Vincent's Drive, Suite 615
Start Date
2011-09
Trial ID
NCT01424644